Immunovant (NASDAQ:IMVT) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Immunovant (IMVT) operate in?

Immunovant is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Immunovant Stock (NASDAQ: IMVT) stock price, news, charts, stock research, profile.

Open	$25.44
Close	$25.86
Volume / Avg.	3.24M / 829.39K
Day Range	$25.25 - $26.27
52 Wk Range	24.61 - 45.58
Market Cap	$3.80B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	19.66%
Days to Cover	13.57

Recent News

IMVT Stock Up on Upbeat Data From Graves' Disease Study of Batoclimab

Shares of Immunovant (NASDAQ: IMVT) are rising in the pre-market hours on Sept. 9 after the company announced positive data from the mid-stage study of its investigational candidate, batoclimab, which is being developed for Graves' Disease.

Zacks

What's Going In With Vivek Ramaswamy-Founded Roivant Sciences Stock On Monday?

Immunovant reports promising Phase 2a trial results for batoclimab in treating Graves' Disease, showing a high response rate and significant IgG reduction. A pivotal trial is expected to start by the end of 2024.

Vandana Singh

Top 2 Health Care Stocks That May Collapse This Quarter

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug

Sep

Oct

Nov

Dec

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$25.44
Close	$25.86
Volume / Avg.	3.24M / 829.39K
Day Range	$25.25 - $26.27
52 Wk Range	24.61 - 45.58
Market Cap	$3.80B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	19.66%
Days to Cover	13.57

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Immunovant (IMVT) stock?

You can purchase shares of Immunovant (NASDAQ:IMVT) through any online brokerage.

View our list of the best stock brokerages

Who are Immunovant (IMVT) competitors?

Other companies in Immunovant’s space includes: Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA), MoonLake (NASDAQ:MLTX), Alkermes (NASDAQ:ALKS) and TG Therapeutics (NASDAQ:TGTX).

What is the forecast, or price target, for Immunovant (IMVT) stock?

Immunovant has a consensus price target of $40.53.

What is the current price for Immunovant (IMVT)?

The stock price for Immunovant (NASDAQ: IMVT) is $25.86 last updated December 20, 2024 at 4:36 PM EST.

Does Immunovant (IMVT) pay a dividend?

There are no upcoming dividends for Immunovant.

When is Immunovant (NASDAQ:IMVT) reporting earnings?

Immunovant’s Q3 earnings are confirmed for Monday, February 10, 2025.

Is Immunovant (IMVT) going to split?

There is no upcoming split for Immunovant.

What sector and industry does Immunovant (IMVT) operate in?

Immunovant is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Immunovant

Immunovant (IMVT) Forecast